Abstract:Despite significant treatment advances, the poor long-term prognosis for children with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) persists. The application of immune cell-based therapies, such as chimeric antigen receptor-expressing T cells and bispecific T-cell engagers, has improved progression-free survival for many B-ALL patients. However, many of these patients still experience disease relapse. While tumours are widely recognized to influence T cell function, this relationship has not been extensively studied in B-ALL. A clinically silent pre-leukemic phase usually precedes childhood B-ALL. Since only a small percentage of children subsequently develop disease, the impact of pre-leukemia on T cell function remains elusive. To address this knowledge gap, we investigated the development of T cell dysfunction in B-ALL and explored ways to restore it using in situ and transplanted leukemia models Using the Emu-Ret transgenic mouse model of hyperdiploid B-ALL, we investigated the induction of exhaustion-associated marker expression (PD-1, CTLA-4 and Tim-3) on T cells. Longitudinal analysis of marker expression revealed that an upregulation of multiple immune checkpoints such as PD-1 and Tim-3, on T cells occurred only in the presence of leukemia cells, not during the extended preleukemia phase. This suggests that T cell exhaustion occurs exclusively during the established malignancy phase, highlighting the evolving nature of T cell responses as disease progresses. Next, we measured exhaustion-associated marker expression in a syngeneic model of transplanted B-ALL. While expression of PD-1 and Tim-3 on T cells correlated with disease progression, a significant increase in these markers was already detectable at low leukemia burden. This indicates that T cell exhaustion is not merely a reflection of high disease burden and highlights the differing impact exerted by preleukemic and leukemic cells on T cells. Phenotypically exhausted T cells from both mouse models showed reduced proliferation, activation, and cytokine secretion. Previously, we have demonstrated the ability of toll-like receptor (TLR) ligands to induce immune control over B-ALL cells. Thus, we investigated the impact of CpG oligodeoxynucleotides (CpG ODN), a ligand for TLR-9, to overcome T cell dysfunction. The treatment of leukemia bearing mice with CpG ODN led to a decrease in PD-1 and Tim-3 expression on T cells, which was also associated with a reduction in leukemia burden. Lastly, the administration of a checkpoint blockade antibodies, with or without TLR agonists as adjuvant therapy led to increased survival of leukemia bearing mice. Overall, this study demonstrates the functional impact of interactions between B-ALL cells and the immune system. The findings from this study may inform therapeutic approaches to overcome B-ALL immune evasion mechanisms and enhance patient outcomes. Citation Format: Tanmaya Atre, Gregor S.D Reid. Reviving exhausted T cells in pediatric B-cell acute lymphoblastic leukemia [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy; 2024 Oct 18-21; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2024;12(10 Suppl) nr B012.

Helios Expression in Regulatory T Cells Promotes Immunosuppression, Angiogenesis and the Growth of Leukemia Cells in Pediatric Acute Lymphoblastic Leukemia

Expression and role of Helios gene in regulatory T cells of pediatric precursor B-cell acute lymphoblastic leukemia

Umbilical cord blood‑derived Helios‑positive regulatory T cells promote angiogenesis in acute lymphoblastic leukemia in mice via CCL22 and the VEGFA‑VEGFR2 pathway.

Expansion and activation of granulocytic, myeloid-derived suppressor cells in childhood precursor B cell acute lymphoblastic leukemia.

Helios—Illuminating the way for lymphocyte self‐control

Phenotypic and functional properties of in vitro-induced Helios+regulatory T cells

Helios characterized circulating follicular helper T cells with enhanced functional phenotypes and was increased in patients with systemic lupus erythematosus

Alterations in Helios+ T Cell Subsets in Peripheral Blood of Early-Stage Lung Adenocarcinoma Patients: Implications for Early Diagnosis

High Percentages of Peripheral Blood T-cell Activation in Childhood Hodgkin's Lymphoma Are Associated with Inferior Outcome.

Co-expression of Foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease

Immunophenotype and Increased Presence of CD4(+)CD25(+) Regulatory T Cells in Patients with Acute Lymphoblastic Leukemia.

Immune Microenvironment Associated with the Severity of Langerhans Cell Histiocytosis in Children.

Somatic FOXC1 insertion mutation remodels the immune microenvironment and promotes the progression of childhood acute lymphoblastic leukemia

Paediatric pre-B acute lymphoblastic leukaemia-derived exosomes regulate immune function in human T cells

Immunologic Function of T Lymphocytes in Children with Acute Lymphocytic Leukemia

Hes1 Mediates the Different Responses of Hematopoietic Stem and Progenitor Cells to T Cell Leukemic Environment.

HELIOS-expressing human CD8 T cells exhibit limited effector functions

Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

Analysis of Regulatory T Cell Subsets and Their Expression of Helios and PD-1 in Patients with Hashimoto Thyroiditis

Effect of Silencing Hoxa5 Gene Expression Using Rna Interference on Cell Cycle and Apoptosis in Jurkat Cells

Abstract B012: Reviving exhausted T cells in pediatric B-cell acute lymphoblastic leukemia